Tumor necrosis factor inhibitor-induced serositis.

Annapureddy, Narender; Agarwal, Shiv Kumar; Ammakkanavar, Natraj; Kanakadandi, Vijay; Sabharwal, Manpreet S; Sanjani, Hari Priya; Simoes, Priya; Nadkarni, Girish N

Annapureddy, Narender; Agarwal, Shiv Kumar; Ammakkanavar, Natraj; Kanakadandi, Vijay; Sabharwal, Manpreet S; Sanjani, Hari Priya; Simoes, Priya; Nadkarni, Girish N.

Afiliação

Annapureddy N; 1Department of Rheumatology, The Orthopedic Building at Rush University Medical Center, Rush University Medical Center, Chicago, IL; 2Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY; 3Department of Hematology/Oncology, Indiana University, Indianapolis, IN; 4Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, MO; 5Department of Cardiology, Albert Einstein College of Medicine, Bronx, NY; 6Osm

Am J Ther ; 21(5): e166-8, 2014.

Article em En | MEDLINE | ID: mdl-23344110

Assuntos

Anticorpos Monoclonais Humanizados/efeitos adversos; Serosite/induzido quimicamente; Fator de Necrose Tumoral alfa/antagonistas & inibidores; Adalimumab; Artrite Psoriásica/tratamento farmacológico; Humanos; Masculino; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serosite / Fator de Necrose Tumoral alfa / Anticorpos Monoclonais Humanizados Limite: Humans / Male / Middle aged Idioma: En Revista: Am J Ther Assunto da revista: TERAPEUTICA Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google